Patents by Inventor Theo Kirkland

Theo Kirkland has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Monoclonal antibodies immunoreactive with lipopolysaccharide binding protein (LBP) and methods of their use
    Patent number: 6884417
    Abstract: The present invention concerns a method of treating LBP-mediated LPS-induced myeloid cell activation comprising administering a therapeutically effective amount of an anti-LBP monoclonal antibody molecule. A therapeutic composition comprising anti-LBP antibody molecules in a pharmaceutically acceptable excipient is also contemplated.
    Type: Grant
    Filed: May 15, 2001
    Date of Patent: April 26, 2005
    Assignee: The Scripps Research Institute
    Inventors: Theo Kirkland, Peter Tobias, Richard Ulevitch, Ann Moriarty, Didier Leturcq
  • Monoclonal antibodies immunoreactive with lipopolysaccharide binding protein (LBP) and methods of their use
    Publication number: 20010029292
    Abstract: The present invention concerns a method of treating LBP-mediated LPS-induced myeloid cell activation comprising administering a therapeutically effective amount of an anti-LBP monoclonal antibody molecule. A therapeutic composition comprising anti-LBP antibody molecules in a pharmaceutically acceptable excipient is also contemplated.
    Type: Application
    Filed: May 15, 2001
    Publication date: October 11, 2001
    Applicant: The Scripps Research Institute
    Inventors: Theo Kirkland, Peter Tobias, Richard Ulevitch, Ann Moriarty, Didier Leturcq
  • Monoclonal antibodies immunoreactive with lipopolysaccharide binding protein (LBP) and methods of their use
    Patent number: 6232080
    Abstract: The present invention concerns a method of treating LBP-mediated LPS-induced myeloid cell activation comprising administering a therapeutically effective amount of an anti-LBP monoclonal antibody molecule. A therapeutic composition comprising anti-LBP antibody molecules in a pharmaceutically acceptable excipient is also contemplated.
    Type: Grant
    Filed: May 19, 1998
    Date of Patent: May 15, 2001
    Assignee: The Scripps Research Institute
    Inventors: Theo Kirkland, Peter Tobias, Richard Ulevitch, Ann Moriarty, Didier Leturcq
  • Monoclonal antibodies immunoreactive with lipopolysaccharide binding protein (LBP) and methods of their use
    Patent number: 5753504
    Abstract: The present invention concerns a method of treating LBP-mediated LPS-induced myeloid cell activation comprising administering a therapeutically effective amount of an anti-LBP monoclonal antibody molecule. A therapeutic composition comprising anti-LBP antibody molecules in a pharmaceutically acceptable excipient is also contemplated.
    Type: Grant
    Filed: July 15, 1996
    Date of Patent: May 19, 1998
    Assignee: The Scripps Research Institute
    Inventors: Theo Kirkland, Peter Tobias, Richard Ulevitch, Ann Moriarty, Didier Leturcq